Research Paper Volume 12, Issue 14 pp 14718—14735
Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling
Figure 6. DMC-BH reduces GSCs intracranial orthotopic growth. (A) GSCs intracranial orthotopic growth after DMC-BH treatment measured by Bioluminescent Imaging (BLI). (B) The average tumor volume in intracranial analyzed by ROI recording. (C) Proliferation of intracranial tumor analyzed using the Ki67 biomarker.